TGTX
TG Therapeutics Inc
56.50$
+1.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
TG Therapeutics Inc (TGTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.0 | -4.1 | -2.6 | -2.3 | -1.2 | -4.5 | -1.4 | -3.5 | -5.7 | -6.2 | -7.8 | -10 | -4.4 | -1.0 | -2.0 | -0.1 | -5.2 | -11 | -35 | -45 | -62 | -94 | -129 | -133 | -215 | -296 | -176 | -31 | -41 | -25 | |
| – | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.3 | 0.4 | 0.5 | 0.5 | 0.4 | 0.3 | 0.1 | |
| – | – | – | – | – | – | – | – | – | – | – | 1.7 | 0.5 | 0.4 | 0.2 | 0.1 | 3.4 | 5.2 | 21 | 16 | 7.5 | 16 | 13 | 11 | 80 | 61 | 19 | 38 | 43 | 65 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.1 | 2.6 | 2.8 | 21 | 16 | 7.4 | 16 | 13 | 11 | 81 | 61 | 19 | – | – | – | |
| -0.6 | 0.1 | -0.1 | -0.1 | 1.7 | -2.0 | 0.1 | -0.1 | 0.1 | 1.0 | 0.2 | 0.0 | -1.0 | -0.2 | 0.2 | 0.4 | 0.7 | 4.1 | -6.0 | 2.1 | 8.8 | 8.6 | 28 | 25 | -20 | -12 | -1.6 | -85 | -109 | -195 | |
| 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.1 | 0.1 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.2 | |
| -0.1 | -0.2 | -0.2 | -0.1 | -0.3 | 2.9 | 0.0 | 0.2 | -4.2 | 3.5 | 1.0 | 0.0 | 0.0 | – | 0.5 | 0.0 | 0.0 | -4.9 | -18 | -25 | 27 | -8.2 | 1.2 | -0.7 | -25 | -0.3 | -20 | -51 | -1.0 | 14 | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | 0.0 | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | – | – | – | – | |
| – | – | – | – | -0.5 | -0.6 | – | 0.0 | 0.0 | – | 0.0 | – | – | – | – | 9.8 | -0.1 | -0.1 | 69 | 69 | 5.0 | 134 | 114 | 175 | 680 | 2.4 | 0.6 | 0.0 | -8.8 | -91 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.2 | – | -0.7 | -0.1 | 0.0 | 30 | 30 | 29 | 40 | 39 | -1.0 | 25 | 137 | 0.0 | |
| 1.3 | 11 | 0.1 | – | 0.7 | 0.5 | 0.0 | 9.0 | 3.4 | 12 | 0.0 | 7.9 | 3.9 | 1.0 | 1.9 | 9.8 | 12 | 40 | 69 | 69 | 5.0 | 134 | 114 | 204 | 680 | 41 | -0.4 | 73 | 129 | -90 | |
| -2.8 | 6.3 | -2.7 | -2.3 | -0.8 | -1.1 | -1.5 | 5.7 | -6.5 | 8.9 | -6.8 | -2.4 | -0.5 | -0.1 | 0.5 | 9.7 | 6.7 | 24 | 15 | -0.7 | -30 | 32 | -14 | 71 | 441 | -255 | -197 | -9.4 | 87 | -101 | |
| -4.1 | -4.3 | -2.8 | -2.4 | -1.3 | -4.6 | -1.4 | -3.5 | -5.8 | -6.3 | -7.8 | -10 | -4.5 | -1.0 | -2.0 | -0.1 | -5.2 | -11 | -35 | -45 | -62 | -94 | -129 | -133 | -215 | -296 | -176 | -31 | -41 | -25 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.